Patients will be excluded if they have had exposure to a total daily dose of MET 1000 mg bid for at least 2 weeks in the past 3 months;
Patients will be excluded if they could not tolerate MET during the recommended titration schedule outlined in the protocol;
Major neurological or medical illnesses that affect weight gain (e.g., unstable thyroid disease) or require a systemic medication that might impact weight or glucose regulation (e.g., diabetes mellitus [insulin], chronic renal failure [steroids]);
Fasting glucose = 126 mg/dL on 2 occasions during screening indicating need for prompt treatment;
If lab results are available in the last 6 months, then a serum creatinine =1.3 mg/dL on 2 occasions during screening and/or follow-up, indicating potential impairment of renal functioning;
Pregnant or breast feeding;
Children and caregivers who are unable to complete assessments for any reason;
